Skip to content

Advertisement

Volume 3 Supplement 1

ESICM LIVES 2015

  • Poster presentation
  • Open Access

Protective effects of low dose stabilized haemoglobin solution in experimental global ischaemia-reperfusion injury

  • 1, 2 and
  • 2
Intensive Care Medicine Experimental20153 (Suppl 1) :A912

https://doi.org/10.1186/2197-425X-3-S1-A912

  • Published:

Keywords

  • Hourly Interval
  • Fluid Administration
  • Bladder Catheterization
  • Venous Cannulation
  • Bovine Haemoglobin

Introduction

We previously reported that low doses of the purified stabilized bovine haemoglobin (EXP1) improved survival in a severe haemorrhage reperfusion model with beneficial effects on oxidative stress (unpublished data). We here report additional findings on a similar formulation, EXP2, at different doses using the same model of shock resuscitation.

Methods

Male Wistar rats (weight 306 ± 15g) underwent arterial and central venous cannulation, tracheostomy, bladder catheterization and placement of a liver tissue pO2 sensor (Oxford Optronix, Oxford, UK). Controlled haemorrhage (45% of estimated blood volume) was induced over 15 minutes and sustained shock (MAP target 40-45 mmHg) was maintained for an additional 75 minutes. After crystalloid resuscitation, animals were randomized to receive a bolus injection of either Ringer's lactate (control) or EXP2 at 200, 400 or 900 mg/kg (New A Innovation Limited, Hong Kong). 700 mg/kg is approximately equivalent to a one-unit blood transfusion. Continuous i.v. fluid administration (10 mg/kg/hr) was then infused for the following 4 hours. Echocardiography, blood gas analysis, blood pressure and liver tissue pO2 were measured pre- and post- insult, and then at hourly intervals. Two-way ANOVA with post-hoc t testing was used to detect statistically significant differences.

Results

Four-hour survival was 50%, 87.5%, 66.7% and 62.5% for the control, 200, 400 and 900 mg/kg groups, respectively. Small but significant changes were seen in plasma Hb levels, no changes were seen in lactate or oxygen delivery, while liver tissue pO2 increased only in the 400 mg/kg group. Notably, urine output improved at all EXP2 doses, particularly in the 900 mg/kg group, though the pressor effect was identical for all doses of EXP2.

Conclusions

Low dose stabilized haemoglobin solution has potential utility in the treatment of global ischaemia-reperfusion injury though further work is needed to clarify optimal dose and mechanism(s) of action.

Grant Acknowledgment

New A Innovation Limited

Figure 1

Figure 2

Figure 3

Authors’ Affiliations

(1)
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milano, Italy
(2)
Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom

Copyright

© Zacchetti et al.; 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement